IHT Wealth Management’s MacroGenics MGNX Stock Holding History

IHT Wealth Management’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-75	Closed	-$1K	–	1442
2017 Q1	$1K	Buy	+75	New	+$1.45K	﹤0.01%	1188

Other funds holding MGNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

IVM

InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

IHT Wealth Management's MGNX Position: Q2 2017 in Review

IHT Wealth Management sold out of MacroGenics (MGNX) in Q2 2017, closing a stake of 75 shares — an estimated $1K sold.

IHT Wealth Management first reported a position in MGNX in Q1 2017 and held it in 1 quarter. The position peaked at $1K in Q1 2017. 113 funds tracked by Wall St. Rank hold MGNX as of Q2 2017.

IHT Wealth Management reported no remaining MacroGenics position as of Q2 2017 after selling out during the quarter.
IHT Wealth Management sold 75 MacroGenics shares in Q2 2017, an estimated $1K.
IHT Wealth Management first reported a position in MacroGenics in Q1 2017 and held it in 1 quarter.
IHT Wealth Management's MacroGenics position peaked at $1K in Q1 2017.
113 funds tracked by Wall St. Rank held MacroGenics as of Q2 2017.

Based on IHT Wealth Management's 13F filing for Q2 2017, filed 14 Aug 2017.